	Anti-GBM glomerulonephritis in a patient with lung adenocarcinoma following pembrolizumab therapy. BMJ Case Rep Abouelyazid R, Fyles F, Tun ZM, Sharma A. PMID: 41887681 [PubMed - indexed for MEDLINE]
	The oncogene c-MYC: an orchestrator of the tumor microenvironment and drug sensitivity in small cell lung cancer. Crit Rev Oncol Hematol Zhao P, Wang Q, Wang X, Tian L, Liu Y, Li H, Liu H. PMID: 41887386 [PubMed - as supplied by publisher]
	The 2021 US Preventive Services Task Force Lung Cancer Screening Criteria Miss Many Patients Diagnosed with Early- and Late-Stage Lung Cancer: Analysis of Three Cohort Studies. Chest Potter AL, Guo Q, Rettner B, Zhu A, Potter A, Zheng W, Kothari J, Shafer A, Martin LW, Pasquinelli MM, Christiani DC, Jeffrey Yang CF. PMID: 41887280 [PubMed - as supplied by publisher]
	Colony-stimulating factors improve neoadjuvant immunochemotherapy efficacy in non-small-cell lung cancer without EGFR or ALK mutations: A double-center real-world retrospective study. Lung Cancer Huang Y, Lin X, Li Z, Fang C, Chen J, Xie X, Wu H, Wang W, Yang H, Fu J. PMID: 41887130 [PubMed - as supplied by publisher]
	Single-center retrospective cohort study of lung cancer associated with interstitial lung disease: Prognostic factors and molecular profile. Lung Cancer Goga A, Soussi G, Mogenet A, Habert P, Fourdrain A, Naud R, Milesi J, Coiffard B, Bermudez J, Pollien E, Gouton E, Barboni M, Reynaud-Gaubert M, Tomasini P, Greillier L, Pluvy J. PMID: 41887129 [PubMed - as supplied by publisher]
	Lung cancer screening by low-dose computed tomography: A modelling study to evaluate radiation-induced cancer risks, and the influence of smoking behavior. Cancer Epidemiol Nicolas M, Agnès R, Christophe B, Julie S, Enora C, Dominique L, Marie-Odile B. PMID: 41886799 [PubMed - as supplied by publisher]
	Final Efficacy and Safety Data From the Phase I/II ARROW Study of Pralsetinib in Patients With Advanced RET Fusion-Positive Non-Small Cell Lung Cancer. J Clin Oncol Besse B, Subbiah V, Curigliano G, Bowles DW, Doebele RC, Mansfield AS, Baik CS, de Lima Lopes G, Paz-Ares L, Taylor MH, Tan DSW, Alonso G, Gadgeel SM, Kalemkerian GP, Ou SI, van der Wekken AJ, Becerra CR, Evangelist M, Griesinger F, Liu SV, Lou Y, Mazières J, Melear JM, Narang M, Saxena A, Thomas M, Wang S, Thomassen A, Lee DH, Kim DW, Gainor JF. PMID: 41886723 [PubMed - as supplied by publisher]
	Systematic Review and Meta-Analysis of Lung Cancer Diagnostic Methods by the Brazilian Thoracic Oncology Group (GBOT). JCO Glob Oncol Cordeiro de Lima VC, Baldotto C, Mascarenhas E, Gelatti ACZ, Mathias C, Araujo LHL, Zukin M, Prado GF, Castro G Jr. PMID: 41886721 [PubMed - indexed for MEDLINE]
	Lung Cancer in Women in Brazil: Incidence, Trends, and Overlooked Risk Factors. JCO Glob Oncol Mascarenhas E, Sternberg C, Vidaurre S, Nascimento E, Greggianin C, Faroni L, Reis T, Gelatti AC, Baldotto C. PMID: 41886717 [PubMed - indexed for MEDLINE]
	Real-World Safety of Immune Checkpoint Inhibitors in Small Cell Lung Cancer: A Systematic Review of Comparative Cohort Studies. Curr Oncol Rep Koo J, Yiu CH, Le HT, Winardi K, Tan ECK, Lu CY. PMID: 41886234 [PubMed - in process]
	Salvage surgery after epidermal growth factor receptor tyrosine kinase inhibitor therapy for non-small cell lung cancer: a focused narrative review. Gen Thorac Cardiovasc Surg Suzuki S, Suzuki T, Okubo Y, Masai K, Kaseda K, Asakura K. PMID: 41886160 [PubMed - as supplied by publisher]
	Impact of COVID-19 vaccination on radiation-induced lung injury in breast cancer patients: a retrospective cohort study. Discov Oncol Ungvári T, Topcsiov ZU, Kedves A, Szabó D, Kiss B, Dankovics Z, Olajos J, T. PMID: 41886012 [PubMed - as supplied by publisher]
	Clinical characteristics, prognostic factors, and feasibility of ICI continuation in immune checkpoint inhibitor-related pneumonitis. Cancer Immunol Immunother Masumoto K, Tsubouchi K, Matsukane R, Yasukochi S, Ogata H, Takano T, Uchida M, Okamoto I. PMID: 41885927 [PubMed - indexed for MEDLINE]
	Combination of Radiotherapy and Immunotherapy in Advanced Non-Small Cell Lung Cancer. JAMA Oncol Zhou H, Wang SC, Lee TTL, Ye ZH, Fang CB, Wai AKC, Hu C, Kong FS. PMID: 41885834 [PubMed - as supplied by publisher]
	Prognostic Interaction between Emphysema and Interstitial Lung Abnormalities for Mortality in a Korean National Lung Cancer Screening Cohort. Radiol Cardiothorac Imaging Kim H, Jo E, Kim J, Goo JM. PMID: 41885620 [PubMed - indexed for MEDLINE]
	Pulmonary Squamous Cell Carcinoma Presenting as Glenoid Bone Metastasis: A Case Report. Orthopedics Zouhbi AE, Daaboul M, El Abiad JM, Zakleet S, Shebly A, Saghieh S, Nassereddine M. PMID: 41885515 [PubMed - indexed for MEDLINE]
	Exploring clinical pathways to a metastatic lung cancer diagnosis: A latent class analysis using North Carolina multi-payer claims data. Cancer Epidemiol Biomarkers Prev Coombs LA, Zhou X, Reeder-Hayes KE, Diaz F, Weiss J, Thompson CA, Lund JL. PMID: 41885380 [PubMed - as supplied by publisher]
	Integrative bioinformatics analysis identifies HCCS as a prognostic and therapeutic biomarker in lung cancer. Cancer Biomark Bellah SF, Hossen MA, Billah SMS. PMID: 41885285 [PubMed - indexed for MEDLINE]
	Clinical Application and Research Progress of (18)F-FDG PET/CT Radiomics in Non-Small Cell Lung Cancer. Zhongguo Yi Xue Ke Xue Yuan Xue Bao Liu W, Wang J. PMID: 41885155 [PubMed - indexed for MEDLINE]
	Efficacy of radiotherapy combined with immunotherapy in driver gene-negative non-small cell lung cancer with brain metastases: A single-center retrospective analysis. J Int Med Res Zhang Z, Li J, Zhou H, Hou L, Wang Y, Zhang M, Zhang Y, Xue X. PMID: 41885095 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 157457

Page 1 of 7873



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy